PDS Biotechnology Past Earnings Performance
Past criteria checks 0/6
PDS Biotechnology's earnings have been declining at an average annual rate of -45.6%, while the Biotechs industry saw earnings growing at 17.7% annually.
Key information
-45.6%
Earnings growth rate
-13.2%
EPS growth rate
Biotechs Industry Growth | -14.6% |
Revenue growth rate | n/a |
Return on equity | -164.3% |
Net Margin | n/a |
Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How PDS Biotechnology makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 23 | 0 | -43 | 15 | 28 |
30 Sep 23 | 0 | -51 | 15 | 36 |
30 Jun 23 | 0 | -48 | 14 | 34 |
31 Mar 23 | 0 | -42 | 13 | 30 |
31 Dec 22 | 0 | -41 | 12 | 29 |
30 Sep 22 | 0 | -28 | 13 | 17 |
30 Jun 22 | 0 | -28 | 13 | 16 |
31 Mar 22 | 0 | -22 | 12 | 15 |
31 Dec 21 | 0 | -17 | 10 | 11 |
30 Sep 21 | 0 | -15 | 9 | 10 |
30 Jun 21 | 0 | -12 | 7 | 9 |
31 Mar 21 | 0 | -14 | 7 | 7 |
31 Dec 20 | 0 | -15 | 7 | 8 |
30 Sep 20 | 0 | -15 | 7 | 7 |
30 Jun 20 | 0 | -17 | 8 | 7 |
31 Mar 20 | 0 | -18 | 9 | 7 |
31 Dec 19 | 0 | -7 | 11 | 6 |
30 Sep 19 | 0 | -5 | 11 | 5 |
30 Jun 19 | 0 | 0 | 8 | 3 |
31 Mar 19 | 0 | 4 | 6 | 2 |
31 Dec 18 | 0 | -4 | 3 | 1 |
30 Sep 18 | 0 | -2 | 2 | 1 |
31 Dec 17 | 0 | -3 | 1 | 2 |
Quality Earnings: EU6 is currently unprofitable.
Growing Profit Margin: EU6 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: EU6 is unprofitable, and losses have increased over the past 5 years at a rate of 45.6% per year.
Accelerating Growth: Unable to compare EU6's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: EU6 is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-11.5%).
Return on Equity
High ROE: EU6 has a negative Return on Equity (-164.33%), as it is currently unprofitable.